Mutant gum disease bacteria offer clue to Alzheimer’s treatment
May 26th, 2010 - 2:42 pm ICT by ANIWashington, May 26 (ANI): Researchers from the University of Florida College of Dentistry claim that a defective, mutant strain of the bacterium that causes gum disease could provide a clue to potential treatments for Alzheimer’s, Parkinson’s and a number of other diseases.
The boffins report their findings at the 110th General Meeting of the American Society for Microbiology in San Diego.
Autophagy, or “self-eating,” is an essential component of cellular survival and defense against invading organisms. It is how the cell degrades and recycles material into amino acids that can be reused. Several neurological disorders, including Parkinson’s and Alzheimer’s disease, are associated with the build up of polypeptides within neurons. Current evidence suggests that if the affected cells could break down these plaque build-ups it would greatly increase the chances of recovery. The ability to activate autophagy within these cells could prove invaluable in the treatment of neurodegenerative disorders.
“Although we do not yet completelt understand how these diseases develop, we do know that the proteins clump together and form a plaque buildup in affected patients’ neurons. If we can direct the cell’s own ability to break down waste products against the plaques, we could keep them from forming and potentially intercept the development of these and other diseases,” says Ann Progulske-Fox, a researcher on the study.
In previous studies Progulske-Fox and her colleagues demonstrated that the bacterium Porphyromonas gingivalis had the ability to activate autophagy when exposed to a human cell line, suggesting the bacterium secreted some unknown substance that initiated the process.
In the current study, they report on a mutant strain of P. gingivalis (PG0717) that does not induce autophagy.
“Understanding how P. gingivalis turns on autophagy in host cells could lead to novel therapeutics for the treatment of neurodegenerative disorders as well as advancements in the general understanding of the autophagic pathway. Study of the mutant will facilitate this understanding and the development of new potential strategies for the treatment of multiple diseases,” says Progulske-Fox. (ANI)
- Novel gene therapy shows promise against Alzheimer's - Mar 05, 2011
- Potential therapeutic target for Parkinson's, Alzheimer's identified - Mar 12, 2011
- A breakthrough in Alzhemier's or Parkinson's treatment? - May 07, 2012
- How misfolded protein spreads from cell to cell, potentially spreading disease - Feb 19, 2011
- How dopamine controls the formation of new neurons in adult brain - Apr 09, 2011
- Turmeric-based drug being tested against Alzheimer's - Feb 15, 2012
- How protein folding could cure Alzheimer, Parkinson diseases - Mar 21, 2011
- Scientists produce compound that may treat Parkinson's disease - Feb 12, 2011
- Protein behind Alzheimer's patients loss of smell? - Sep 29, 2011
- What causes brain cell death in Parkinson's patients - Jan 08, 2011
- Clogged arteries can also cause clouded thinking - Jul 22, 2011
- Cancer-causing H. pylori bug spurs cell death - Nov 02, 2011
- Alzheimer's drugs may have serious side-effects - Feb 20, 2012
- Strawberries show promise against Huntington's disease - Nov 16, 2010
- Delivering drugs directly to brain may help Alzheimer's sufferers - Mar 21, 2011
Tags: american society for microbiology, amino acids, autophagy, bacterium, boffins, clump, college of dentistry, disease bacteria, florida college, gum disease, host cells, mutant strain, neurodegenerative disorders, neurological disorders, novel therapeutics, plaque buildup, polypeptides, university of florida, university of florida college of dentistry, ups